These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 5998705)

  • 1. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E; Marcer V
    Fracastoro; 1966; 59(6):621-38. PubMed ID: 5998705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF; Droznina TA; Markelov IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease].
    Hooft C; De Laey P; Lambert Y
    Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systematic use of organ enzymograms. 3. Muscle enzymograms].
    Gambella O; Peracino A; Levis F
    Minerva Med; 1970 Nov; 61(94):5349-58. PubMed ID: 5489533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive chronic ophthalmoplegia. (Clinical, biochemical, histological and electromyographic findings in a family with primary ocular myopathy)].
    Bernardi G; Bonanni R; Vasconetto C
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1093-105. PubMed ID: 5760318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to enzymatic study in liquor and serum of different amyotrophic entities (author's transl)].
    Nieto Vales JM; Rodríguez Navarro I
    Folia Clin Int (Barc); 1973 Feb; 23(2):86-109. PubMed ID: 4804725
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allopurinol in progressive muscular dystrophy (author's transl)].
    Castro-Gago M; Jiménez JF; Torres-Colomer M; Fuster M; Paz M; Novo I; Peña J
    An Esp Pediatr; 1980 Oct; 13(10):865-76. PubMed ID: 7469188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differentiation and dedifferentiation of muscular dystrophy].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Oct; 26(10):2423-42. PubMed ID: 5752013
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the enzyme activity of muscle tissue in progressive muscular dystrophy].
    Badalian LO; Tamarkina ED; Bondarenko ES; Zakoshchikova LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):72-6. PubMed ID: 5425803
    [No Abstract]   [Full Text] [Related]  

  • 15. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fatal diffuse rhabdomyolysis during salicylate and nifuroxazide poisoning].
    Bismuth C; Fréjaville JP; Pebay-Peyroula F; Leclerc JP
    Nouv Presse Med; 1972 Feb; 1(6):397-9. PubMed ID: 5010137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Muscular system in human trichinosis based on electromyographic, histological and enzyme tests].
    Kowalczyk M; Poznańska H; Emeryk-Szajewska B; Fidziańska-Dolot A
    Przegl Epidemiol; 1969; 23(4):489-99. PubMed ID: 5369052
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M; Rivron M; Landrieu P
    Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.